IL230665D0
17-hydroxyprogesterone ester -containing oral compositions and related methods
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
45 members in 14 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 201113193571 | United States of America | A | |
| 2012048708 | United States of America | W | |
| 13193571 | – | – | – |
| PCTUS2012048708 | – | – | – |
| US201113193571 | – | – | – |
| WO2012US48708 | – | – | – |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| CA2879401A1 | Canada | A1 | |
| US2013029957A1 | United States of America | A1 | |
| WO2013016697A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2013016697A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2012286620A1 | Australia | A1 | |
| IL230665D0This record | Israel | D0 | |
| CN103826640A | China | A | |
| KR20140064819A | Republic of Korea | A | |
| EP2736515A2 | European Patent Office (EPO) | A2 | |
| JP2014521660A | Japan | A | |
| US2014271882A1 | United States of America | A1 | |
| ZA201401464B | South Africa | B | |
| EP2736515A4 | European Patent Office (EPO) | A4 | |
| US2014377317A1 | United States of America | A1 | |
| US8951996B2 | United States of America | B2 | |
| US2015165049A1 | United States of America | A1 | |
| RU2014102285A | Russian Federation | A | |
| US2015320768A1 | United States of America | A1 | |
| US9358298B2 | United States of America | B2 | |
| US9358299B2 | United States of America | B2 | |
| US9364547B2 | United States of America | B2 | |
| US9399069B2 | United States of America | B2 | |
| US2016213686A1 | United States of America | A1 | |
| NZ620698A | New Zealand | A | |
| US2017007623A1 | United States of America | A1 | |
| BR112014001942A2 | Brazil | A2 | |
| AU2012286620B2 | Australia | B2 | |
| CA2879401C | Canada | C | |
| JP2017193554A | Japan | A | |
| RU2640912C2 | Russian Federation | C2 | |
| IL230665A | Israel | A | |
| IL230665B | Israel | B | |
| US10022384B2 | United States of America | B2 | |
| CN108514545A | China | A | |
| US2018289724A1 | United States of America | A1 | |
| JP6479470B2 | Japan | B2 | |
| KR101957264B1 | Republic of Korea | B1 | |
| MX2014001101A | Mexico | A | |
| US2019307775A1 | United States of America | A1 | |
| BR112014001942B1 | Brazil | B1 | |
| EP2736515B1 | European Patent Office (EPO) | B1 | |
| US10709716B2 | United States of America | B2 | |
| EP3763360A1 | European Patent Office (EPO) | A1 | |
| US2021106596A1 | United States of America | A1 | |
| US11471470B2 | United States of America | B2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 230665
- Publication, DOCDB
- 230665
- Publication, EPODOC
- IL230665D
- Application
- 230665
- Application, DOCDB
- 23066514
- Application, EPODOC
- IL20140230665
Titles2
- English
- 17-hydroxyprogesterone ester -containing oral compositions and related methods
- Hebrew
- תכשירים פומיים המכילים 17 –הידרוקסיפרוגסטרון אסטר ושימושיהם
Classification
- CPC, 44
- A61K31/57
- A61K9/2054
- A61K8/63
- A61K9/2059
- A61K9/0053
- A61K9/145
- A61K9/14
- A61K9/1617
- A61K9/1623
- A61K9/1635
- A61K9/1641
- A61K9/1652
- A61K9/1676
- A61K9/2018
- A61K9/4858
- A61K9/2013
- A61K9/4866
- A61K9/2031
- A61P15/00
- A61P15/06
- A61P15/08
- A61K9/4841
- A61P15/12
- A61P17/00
- A61P17/06
- A61K47/10
- A61P17/08
- A61K47/12
- A61P17/10
- A61K47/14
- A61P19/10
- A61K47/20
- A61P25/00
- A61K47/22
- A61P25/24
- A61K47/26
- A61P5/00
- A61K47/32
- A61P5/30
- A61K47/44
- A61P7/04
- A61K2800/10
- A61P9/10
- A61Q11/00
- IPC, 1
- A61K